Literature DB >> 4038634

In vivo turnover studies of C-reactive protein.

M L Baltz, I F Rowe, M B Pepys.   

Abstract

The in vivo plasma clearance rate of the acute phase reactant C-reactive protein (CRP) was studied in mice and rats. The clearance rate of 125I-human CRP in mice and 125I-rat CRP in rats showed a T1/2 of approximately 4 h. The T1/2 was independent of circulating levels of CRP and was not affected by the presence of C-polysaccharide (CPS), a ligand to which CRP binds. However, in mice receiving sufficient CPS, more radioactivity localized to the spleen compared to mice receiving 125I-CRP only. 125I-CPS was rapidly cleared at the same rate by normal mice and by mice undergoing an acute phase response while rats cleared 125I-CPS more slowly despite having high circulating CRP concentrations. These findings suggest that CRP does not provide a mechanism for extremely rapid clearance of its ligands from the circulation, although the handling and subsequent fate of these ligands may be affected.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4038634      PMCID: PMC1577160     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

1.  Preparation of iodine-131 labelled human growth hormone of high specific activity.

Authors:  W M HUNTER; F C GREENWOOD
Journal:  Nature       Date:  1962-05-05       Impact factor: 49.962

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Limulin: a C-reactive protein from Limulus polyphemus.

Authors:  F A Robey; T Y Liu
Journal:  J Biol Chem       Date:  1981-01-25       Impact factor: 5.157

4.  Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in mice.

Authors:  J Yother; J E Volanakis; D E Briles
Journal:  J Immunol       Date:  1982-05       Impact factor: 5.422

5.  A fluorescent immunoassay for the quantification of C-reactive protein.

Authors:  R Siboo; E Kulisek
Journal:  J Immunol Methods       Date:  1978       Impact factor: 2.303

6.  The role of the spleen in the protective effect of C-reactive protein in Streptococcus pneumoniae infection.

Authors:  S Nakayama; H Gewurz; T Holzer; T W Du Clos; C Mold
Journal:  Clin Exp Immunol       Date:  1983-11       Impact factor: 4.330

7.  Isolation of human C-reactive protein and serum amyloid P component.

Authors:  F C De Beer; M B Pepys
Journal:  J Immunol Methods       Date:  1982       Impact factor: 2.303

8.  Isolation and characterization of C-reactive protein and serum amyloid P component in the rat.

Authors:  F C de Beer; M L Baltz; E A Munn; A Feinstein; J Taylor; C Bruton; J R Clamp; M B Pepys
Journal:  Immunology       Date:  1982-01       Impact factor: 7.397

9.  Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril.

Authors:  P J Fraker; J C Speck
Journal:  Biochem Biophys Res Commun       Date:  1978-02-28       Impact factor: 3.575

10.  Control of the acute phase response. Demonstration of C-reactive protein synthesis and secretion by hepatocytes during acute inflammation in the rabbit.

Authors:  I Kushner; G Feldmann
Journal:  J Exp Med       Date:  1978-08-01       Impact factor: 14.307

View more
  8 in total

1.  Proinflammatory effects of bacterial recombinant human C-reactive protein are caused by contamination with bacterial products, not by C-reactive protein itself.

Authors:  Mark B Pepys; Philip N Hawkins; Melvyn C Kahan; Glenys A Tennent; J Ruth Gallimore; David Graham; Caroline A Sabin; Arturo Zychlinsky; Juana de Diego
Journal:  Circ Res       Date:  2005-10-27       Impact factor: 17.367

2.  Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure.

Authors:  M B Pepys; T W Rademacher; S Amatayakul-Chantler; P Williams; G E Noble; W L Hutchinson; P N Hawkins; S R Nelson; J R Gallimore; J Herbert
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

3.  Role of the property of C-reactive protein to activate the classical pathway of complement in protecting mice from pneumococcal infection.

Authors:  Madathilparambil V Suresh; Sanjay K Singh; Donald A Ferguson; Alok Agrawal
Journal:  J Immunol       Date:  2006-04-01       Impact factor: 5.422

4.  Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease.

Authors:  D M Vigushin; M B Pepys; P N Hawkins
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

5.  CRP and neutrophils: functional effects and complex uptake.

Authors:  E G Shephard; R Anderson; A F Strachan; S H Kühn; F C De Beer
Journal:  Clin Exp Immunol       Date:  1986-03       Impact factor: 4.330

6.  Macrophages activated by C-reactive protein through Fc gamma RI transfer suppression of immune thrombocytopenia.

Authors:  Kristopher D Marjon; Lorraine L Marnell; Carolyn Mold; Terry W Du Clos
Journal:  J Immunol       Date:  2009-02-01       Impact factor: 5.422

7.  Lack of effect of a single injection of human C-reactive protein on murine lupus or nephrotoxic nephritis.

Authors:  Francesco Carlucci; H Terence Cook; Abhilok Garg; Mark B Pepys; Marina Botto
Journal:  Arthritis Rheum       Date:  2010-01

8.  Isolation and characterization of pharmaceutical grade human pentraxins, serum amyloid P component and C-reactive protein, for clinical use.

Authors:  Mark B Pepys; J Ruth Gallimore; Joanne Lloyd; Zhanhong Li; David Graham; Graham W Taylor; Stephan Ellmerich; Palma P Mangione; Glenys A Tennent; Winston L Hutchinson; David J Millar; Gary Bennett; John More; David Evans; Yogesh Mistry; Stephen Poole; Philip N Hawkins
Journal:  J Immunol Methods       Date:  2012-07-31       Impact factor: 2.303

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.